Molecular Weight:   | 300.17 |
Volume:   | 336.539 |
LogP:   | 5.52 |
LogD:   | 3.916 |
LogS:   | -4.699 |
# Rotatable Bonds:   | 6 |
TPSA:   | 57.53 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 3 |
QED Drug-Likeness Score:   | 0.6 |
Synthetic Accessibility Score:   | 2.781 |
Fsp3:   | 0.316 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Rejected |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.972 |
MDCK Permeability:   | 1.577451803314034e-05 |
Pgp-inhibitor:   | 0.022 |
Pgp-substrate:   | 0.123 |
Human Intestinal Absorption (HIA):   | 0.019 |
20% Bioavailability (F20%):   | 0.862 |
30% Bioavailability (F30%):   | 0.573 |
Blood-Brain-Barrier Penetration (BBB):   | 0.048 |
Plasma Protein Binding (PPB):   | 92.7042007446289% |
Volume Distribution (VD):   | 0.443 |
Pgp-substrate:   | 5.175224304199219% |
CYP1A2-inhibitor:   | 0.193 |
CYP1A2-substrate:   | 0.122 |
CYP2C19-inhibitor:   | 0.043 |
CYP2C19-substrate:   | 0.064 |
CYP2C9-inhibitor:   | 0.418 |
CYP2C9-substrate:   | 0.292 |
CYP2D6-inhibitor:   | 0.211 |
CYP2D6-substrate:   | 0.131 |
CYP3A4-inhibitor:   | 0.039 |
CYP3A4-substrate:   | 0.08 |
Clearance (CL):   | 11.621 |
Half-life (T1/2):   | 0.83 |
hERG Blockers:   | 0.027 |
Human Hepatotoxicity (H-HT):   | 0.93 |
Drug-inuced Liver Injury (DILI):   | 0.068 |
AMES Toxicity:   | 0.006 |
Rat Oral Acute Toxicity:   | 0.048 |
Maximum Recommended Daily Dose:   | 0.283 |
Skin Sensitization:   | 0.941 |
Carcinogencity:   | 0.122 |
Eye Corrosion:   | 0.008 |
Eye Irritation:   | 0.26 |
Respiratory Toxicity:   | 0.359 |
Natural Product ID:   | NPC243677 |
Common Name*:   | Artepillin |
IUPAC Name:   | (E)-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-enoic acid |
Synonyms:   | Artepillin; Artepillin C |
Standard InCHIKey:   | KABCFARPAMSXCC-JXMROGBWSA-N |
Standard InCHI:   | InChI=1S/C19H24O3/c1-13(2)5-8-16-11-15(7-10-18(20)21)12-17(19(16)22)9-6-14(3)4/h5-7,10-12,22H,8-9H2,1-4H3,(H,20,21)/p-1/b10-7+ |
SMILES:   | CC(=CCc1cc(/C=C/C(=O)[O-])cc(CC=C(C)C)c1O)C |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL456309 |
PubChem CID:   |
5472440 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO30782 | Brazilian propolis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | DOI[10.1248/cpb.47.1521] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[10654410] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[10843587] |
NPO30782 | Brazilian propolis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
PMID[11000036] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[15568770] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[16392664] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[16933887] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | roots | Hualien Hsien, Taiwan | 2003-JUL |
PMID[16933887] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | n.a. | n.a. |
PMID[17548953] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[17951038] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[18175961] |
NPO13379 | Schizanthus tricolor | Species | Solanaceae | Eukaryota | Aerial parts | n.a. | n.a. |
PMID[20166702] |
NPO11266 | Garcinia cambogia | Species | Clusiaceae | Eukaryota | n.a. | exocarp | n.a. |
PMID[21114277] |
NPO13379 | Schizanthus tricolor | Species | Solanaceae | Eukaryota | n.a. | aerial part | n.a. |
PMID[21171571] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | whole plant | n.a. |
PMID[21428416] |
NPO32851 | brazilian green propolis | Species | n.a. | n.a. | n.a. | Brazilian green propolis | n.a. |
PMID[21865046] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22870812] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23435948] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24295087] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24675423] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | Bako, Ethiopia |
PMID[24926420] |
|
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | Enemore, Ethiopia |
PMID[24926420] |
|
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | Gedo, Ethiopia |
PMID[24926420] |
|
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | Holleta, Ethiopia |
PMID[24926420] |
|
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[25737008] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[27575476] |
NPO3013 | Clathria basilana | Species | Microcionidae | Eukaryota | n.a. | n.a. | n.a. |
PMID[29094598] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[30298740] |
NPO30782 | Brazilian propolis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
PMID[8951168] |
NPO30782 | Brazilian propolis | n.a. | n.a. | n.a. | n.a. | Brazilian propolis | n.a. |
PMID[9677271] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[9868163] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. | Database[Article] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11842 | Petasites laevigatus | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO13473 | Anodendron affine | Species | Apocynaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7541 | Ormosia hosiei | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11266 | Garcinia cambogia | Species | Clusiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7541 | Ormosia hosiei | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO11842 | Petasites laevigatus | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO13473 | Anodendron affine | Species | Apocynaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO11266 | Garcinia cambogia | Species | Clusiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO31579 | Artemisia capillaries | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO7541 | Ormosia hosiei | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO11842 | Petasites laevigatus | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7541 | Ormosia hosiei | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO14470 | Polypodium decumanum | Species | Polypodiidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO14169 | Acrocarpia paniculata | Species | Sargassaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11266 | Garcinia cambogia | Species | Clusiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13669 | Hertia cheirifolia | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13178 | Ornithoglossum viride | Species | Colchicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO5280 | Rubia tetragona | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12006 | Apis mellifera | Species | Apidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13876 | Cedrela salvadorensis | Species | Meliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO14369 | Pocillopora eydouxi | Species | Pocilloporidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13473 | Anodendron affine | Species | Apocynaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9569 | Licaria chrysophylla | Species | Lauraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4700 | Pertusaria truncata | Species | Pertusariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13379 | Schizanthus tricolor | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12521 | Sphaeranthus confertifolius | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO3013 | Clathria basilana | Species | Microcionidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT453 | Cell Line | HT-1080 | Homo sapiens | ED50 | = | 45.47 | ug ml-1 | PMID[465873] |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 7.0 | ug.mL-1 | PMID[465874] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Activity | = | 53.3 | % | PMID[465875] |
NPT41 | Individual Protein | Aldose reductase | Homo sapiens | IC50 | = | 23000.0 | nM | PMID[465876] |
NPT1270 | Individual Protein | Aldo-keto reductase family 1 member B10 | Homo sapiens | IC50 | = | 53000.0 | nM | PMID[465876] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 87498.38 | nM | PMID[465877] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 19678.86 | nM | PMID[465877] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 76032.63 | nM | PMID[465877] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 31332.86 | nM | PMID[465877] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 76032.63 | nM | PMID[465877] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 76559.66 | nM | PMID[465877] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 43651.58 | nM | PMID[465877] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 76032.63 | nM | PMID[465877] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 81658.24 | nM | PMID[465877] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 66834.39 | nM | PMID[465877] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 73451.39 | nM | PMID[465877] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 47315.13 | nM | PMID[465877] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PMID[465877] |
NPT3504 | Individual Protein | Aldo-keto-reductase family 1 member C3 | Homo sapiens | IC50 | = | 1000.0 | nM | PMID[465878] |
NPT3506 | Individual Protein | Aldo-keto reductase family 1 member C4 | Homo sapiens | Inhibition | = | 19.0 | % | PMID[465878] |
NPT3507 | Individual Protein | Aldo-keto reductase family 1 member C2 | Homo sapiens | Inhibition | = | 13.0 | % | PMID[465878] |
NPT3504 | Individual Protein | Aldo-keto-reductase family 1 member C3 | Homo sapiens | Ki | = | 680.0 | nM | PMID[465878] |
NPT3505 | Individual Protein | Aldo-keto reductase family 1 member C1 | Homo sapiens | Inhibition | = | 29.0 | % | PMID[465878] |
NPT3120 | Individual Protein | Serine/threonine-protein kinase PAK 1 | Homo sapiens | IC50 | = | 25000.0 | nM | PMID[465879] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 25000.0 | nM | PMID[465879] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 59.32 | ug ml-1 | PMID[465873] |
NPT2 | Others | Unspecified | Ratio | = | 1.09 | n.a. | PMID[465875] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Inhibition | = | 80.9 | % | PMID[465875] |
NPT2 | Others | Unspecified | ED | = | 20.0 | uM | PMID[465879] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC243677 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9796 | High Similarity | NPC303141 |
0.97 | High Similarity | NPC470039 |
0.9592 | High Similarity | NPC470202 |
0.9412 | High Similarity | NPC75272 |
0.9412 | High Similarity | NPC471954 |
0.898 | High Similarity | NPC246679 |
0.8878 | High Similarity | NPC32977 |
0.8878 | High Similarity | NPC81010 |
0.8818 | High Similarity | NPC474890 |
0.8818 | High Similarity | NPC161943 |
0.8818 | High Similarity | NPC273282 |
0.8807 | High Similarity | NPC83718 |
0.8785 | High Similarity | NPC199462 |
0.8713 | High Similarity | NPC128723 |
0.8673 | High Similarity | NPC204210 |
0.866 | High Similarity | NPC70436 |
0.8627 | High Similarity | NPC253746 |
0.8627 | High Similarity | NPC225506 |
0.8624 | High Similarity | NPC114918 |
0.8614 | High Similarity | NPC77492 |
0.8611 | High Similarity | NPC228988 |
0.86 | High Similarity | NPC144682 |
0.86 | High Similarity | NPC8392 |
0.8598 | High Similarity | NPC473809 |
0.8586 | High Similarity | NPC181709 |
0.8559 | High Similarity | NPC263754 |
0.8559 | High Similarity | NPC183154 |
0.8532 | High Similarity | NPC242136 |
0.8529 | High Similarity | NPC122005 |
0.8529 | High Similarity | NPC252821 |
0.8519 | High Similarity | NPC139946 |
0.8519 | High Similarity | NPC228609 |
0.85 | High Similarity | NPC289769 |
0.8491 | Intermediate Similarity | NPC228737 |
0.8476 | Intermediate Similarity | NPC138942 |
0.8469 | Intermediate Similarity | NPC123273 |
0.8469 | Intermediate Similarity | NPC177420 |
0.8469 | Intermediate Similarity | NPC242240 |
0.8469 | Intermediate Similarity | NPC318325 |
0.8469 | Intermediate Similarity | NPC280347 |
0.8462 | Intermediate Similarity | NPC135784 |
0.8462 | Intermediate Similarity | NPC304638 |
0.8462 | Intermediate Similarity | NPC168829 |
0.8431 | Intermediate Similarity | NPC201967 |
0.8426 | Intermediate Similarity | NPC183700 |
0.8416 | Intermediate Similarity | NPC26244 |
0.8416 | Intermediate Similarity | NPC257182 |
0.8411 | Intermediate Similarity | NPC279887 |
0.8411 | Intermediate Similarity | NPC68260 |
0.8384 | Intermediate Similarity | NPC55561 |
0.8381 | Intermediate Similarity | NPC288411 |
0.8381 | Intermediate Similarity | NPC93831 |
0.8367 | Intermediate Similarity | NPC113460 |
0.8367 | Intermediate Similarity | NPC25493 |
0.8365 | Intermediate Similarity | NPC472585 |
0.8364 | Intermediate Similarity | NPC211421 |
0.8362 | Intermediate Similarity | NPC174991 |
0.835 | Intermediate Similarity | NPC130193 |
0.835 | Intermediate Similarity | NPC245561 |
0.8333 | Intermediate Similarity | NPC473388 |
0.8333 | Intermediate Similarity | NPC26013 |
0.8333 | Intermediate Similarity | NPC283711 |
0.8333 | Intermediate Similarity | NPC282855 |
0.8318 | Intermediate Similarity | NPC260952 |
0.8317 | Intermediate Similarity | NPC128062 |
0.8317 | Intermediate Similarity | NPC151715 |
0.8304 | Intermediate Similarity | NPC471936 |
0.8302 | Intermediate Similarity | NPC99557 |
0.8302 | Intermediate Similarity | NPC219286 |
0.8288 | Intermediate Similarity | NPC197513 |
0.8288 | Intermediate Similarity | NPC41851 |
0.8286 | Intermediate Similarity | NPC108497 |
0.8283 | Intermediate Similarity | NPC258219 |
0.8276 | Intermediate Similarity | NPC475192 |
0.8276 | Intermediate Similarity | NPC67300 |
0.8269 | Intermediate Similarity | NPC52472 |
0.8265 | Intermediate Similarity | NPC407 |
0.8265 | Intermediate Similarity | NPC23167 |
0.8265 | Intermediate Similarity | NPC307235 |
0.8257 | Intermediate Similarity | NPC63345 |
0.8257 | Intermediate Similarity | NPC208229 |
0.8252 | Intermediate Similarity | NPC140619 |
0.8241 | Intermediate Similarity | NPC61885 |
0.8241 | Intermediate Similarity | NPC206341 |
0.8241 | Intermediate Similarity | NPC31274 |
0.8241 | Intermediate Similarity | NPC63698 |
0.8235 | Intermediate Similarity | NPC286006 |
0.823 | Intermediate Similarity | NPC122117 |
0.8224 | Intermediate Similarity | NPC69332 |
0.8224 | Intermediate Similarity | NPC95178 |
0.8224 | Intermediate Similarity | NPC29989 |
0.8224 | Intermediate Similarity | NPC271274 |
0.819 | Intermediate Similarity | NPC51015 |
0.819 | Intermediate Similarity | NPC94343 |
0.8182 | Intermediate Similarity | NPC470355 |
0.8173 | Intermediate Similarity | NPC171843 |
0.8165 | Intermediate Similarity | NPC88141 |
0.8165 | Intermediate Similarity | NPC98392 |
0.8165 | Intermediate Similarity | NPC95172 |
0.8165 | Intermediate Similarity | NPC79543 |
0.8163 | Intermediate Similarity | NPC155393 |
0.8163 | Intermediate Similarity | NPC197783 |
0.8151 | Intermediate Similarity | NPC473751 |
0.8137 | Intermediate Similarity | NPC316301 |
0.8137 | Intermediate Similarity | NPC27323 |
0.8137 | Intermediate Similarity | NPC152415 |
0.8136 | Intermediate Similarity | NPC184219 |
0.8131 | Intermediate Similarity | NPC127676 |
0.8131 | Intermediate Similarity | NPC227255 |
0.8119 | Intermediate Similarity | NPC304541 |
0.8119 | Intermediate Similarity | NPC270547 |
0.8119 | Intermediate Similarity | NPC306074 |
0.8119 | Intermediate Similarity | NPC45040 |
0.8113 | Intermediate Similarity | NPC13426 |
0.8113 | Intermediate Similarity | NPC68269 |
0.8108 | Intermediate Similarity | NPC286222 |
0.8103 | Intermediate Similarity | NPC131868 |
0.8103 | Intermediate Similarity | NPC241001 |
0.8103 | Intermediate Similarity | NPC164852 |
0.81 | Intermediate Similarity | NPC98772 |
0.8095 | Intermediate Similarity | NPC248396 |
0.8095 | Intermediate Similarity | NPC129373 |
0.8095 | Intermediate Similarity | NPC48730 |
0.8091 | Intermediate Similarity | NPC222905 |
0.8091 | Intermediate Similarity | NPC296683 |
0.8087 | Intermediate Similarity | NPC473767 |
0.8083 | Intermediate Similarity | NPC243688 |
0.8081 | Intermediate Similarity | NPC184169 |
0.8077 | Intermediate Similarity | NPC260000 |
0.8077 | Intermediate Similarity | NPC152097 |
0.8073 | Intermediate Similarity | NPC262365 |
0.807 | Intermediate Similarity | NPC278652 |
0.807 | Intermediate Similarity | NPC160199 |
0.807 | Intermediate Similarity | NPC174087 |
0.8061 | Intermediate Similarity | NPC248817 |
0.8061 | Intermediate Similarity | NPC286904 |
0.8061 | Intermediate Similarity | NPC175313 |
0.8056 | Intermediate Similarity | NPC70843 |
0.8056 | Intermediate Similarity | NPC1786 |
0.8056 | Intermediate Similarity | NPC1075 |
0.8056 | Intermediate Similarity | NPC294902 |
0.8039 | Intermediate Similarity | NPC138117 |
0.8039 | Intermediate Similarity | NPC162314 |
0.8039 | Intermediate Similarity | NPC3358 |
0.8039 | Intermediate Similarity | NPC325292 |
0.8039 | Intermediate Similarity | NPC94139 |
0.8039 | Intermediate Similarity | NPC210497 |
0.8039 | Intermediate Similarity | NPC147284 |
0.8039 | Intermediate Similarity | NPC306884 |
0.8037 | Intermediate Similarity | NPC2518 |
0.8037 | Intermediate Similarity | NPC261573 |
0.8037 | Intermediate Similarity | NPC120693 |
0.8037 | Intermediate Similarity | NPC8931 |
0.8036 | Intermediate Similarity | NPC296144 |
0.8036 | Intermediate Similarity | NPC28784 |
0.8034 | Intermediate Similarity | NPC251259 |
0.802 | Intermediate Similarity | NPC300017 |
0.802 | Intermediate Similarity | NPC192 |
0.8018 | Intermediate Similarity | NPC225679 |
0.8018 | Intermediate Similarity | NPC4493 |
0.8018 | Intermediate Similarity | NPC165770 |
0.8018 | Intermediate Similarity | NPC95716 |
0.8018 | Intermediate Similarity | NPC476632 |
0.8017 | Intermediate Similarity | NPC478121 |
0.8017 | Intermediate Similarity | NPC193203 |
0.8017 | Intermediate Similarity | NPC229894 |
0.8 | Intermediate Similarity | NPC80027 |
0.8 | Intermediate Similarity | NPC132078 |
0.8 | Intermediate Similarity | NPC92730 |
0.8 | Intermediate Similarity | NPC280869 |
0.8 | Intermediate Similarity | NPC216468 |
0.8 | Intermediate Similarity | NPC51333 |
0.8 | Intermediate Similarity | NPC260775 |
0.8 | Intermediate Similarity | NPC309434 |
0.8 | Intermediate Similarity | NPC203124 |
0.8 | Intermediate Similarity | NPC78119 |
0.7983 | Intermediate Similarity | NPC89630 |
0.7983 | Intermediate Similarity | NPC265413 |
0.7983 | Intermediate Similarity | NPC10154 |
0.7982 | Intermediate Similarity | NPC226699 |
0.7982 | Intermediate Similarity | NPC151477 |
0.7981 | Intermediate Similarity | NPC216520 |
0.7981 | Intermediate Similarity | NPC82664 |
0.7981 | Intermediate Similarity | NPC292730 |
0.7981 | Intermediate Similarity | NPC132271 |
0.7966 | Intermediate Similarity | NPC121168 |
0.7965 | Intermediate Similarity | NPC473931 |
0.7965 | Intermediate Similarity | NPC474050 |
0.7965 | Intermediate Similarity | NPC474114 |
0.7963 | Intermediate Similarity | NPC13495 |
0.7963 | Intermediate Similarity | NPC474839 |
0.7959 | Intermediate Similarity | NPC265146 |
0.7959 | Intermediate Similarity | NPC124436 |
0.7951 | Intermediate Similarity | NPC117899 |
0.7946 | Intermediate Similarity | NPC26615 |
0.7946 | Intermediate Similarity | NPC43525 |
0.7946 | Intermediate Similarity | NPC17693 |
0.7946 | Intermediate Similarity | NPC46940 |
0.7946 | Intermediate Similarity | NPC228425 |
0.7944 | Intermediate Similarity | NPC269212 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC243677 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.86 | High Similarity | NPD1809 | Phase 2 |
0.8586 | High Similarity | NPD845 | Approved |
0.8416 | Intermediate Similarity | NPD2859 | Approved |
0.8416 | Intermediate Similarity | NPD2860 | Approved |
0.8317 | Intermediate Similarity | NPD2933 | Approved |
0.8317 | Intermediate Similarity | NPD2934 | Approved |
0.819 | Intermediate Similarity | NPD846 | Approved |
0.819 | Intermediate Similarity | NPD940 | Approved |
0.8174 | Intermediate Similarity | NPD4626 | Approved |
0.8173 | Intermediate Similarity | NPD3020 | Approved |
0.8137 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.8087 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.8058 | Intermediate Similarity | NPD844 | Approved |
0.7959 | Intermediate Similarity | NPD111 | Approved |
0.7857 | Intermediate Similarity | NPD6124 | Clinical (unspecified phase) |
0.7818 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.781 | Intermediate Similarity | NPD288 | Approved |
0.7778 | Intermediate Similarity | NPD5691 | Approved |
0.7769 | Intermediate Similarity | NPD1164 | Approved |
0.7757 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7748 | Intermediate Similarity | NPD9266 | Approved |
0.7748 | Intermediate Similarity | NPD74 | Approved |
0.7727 | Intermediate Similarity | NPD3134 | Approved |
0.7719 | Intermediate Similarity | NPD7159 | Clinical (unspecified phase) |
0.7672 | Intermediate Similarity | NPD9493 | Approved |
0.7658 | Intermediate Similarity | NPD9267 | Approved |
0.7658 | Intermediate Similarity | NPD9264 | Approved |
0.7658 | Intermediate Similarity | NPD9263 | Approved |
0.7632 | Intermediate Similarity | NPD7635 | Approved |
0.7589 | Intermediate Similarity | NPD6831 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD256 | Approved |
0.7586 | Intermediate Similarity | NPD255 | Approved |
0.7583 | Intermediate Similarity | NPD422 | Phase 1 |
0.7542 | Intermediate Similarity | NPD9545 | Approved |
0.7522 | Intermediate Similarity | NPD3022 | Approved |
0.7522 | Intermediate Similarity | NPD3021 | Approved |
0.75 | Intermediate Similarity | NPD1358 | Approved |
0.75 | Intermediate Similarity | NPD2342 | Discontinued |
0.75 | Intermediate Similarity | NPD4208 | Discontinued |
0.75 | Intermediate Similarity | NPD4212 | Discontinued |
0.7462 | Intermediate Similarity | NPD2935 | Discontinued |
0.744 | Intermediate Similarity | NPD4207 | Discontinued |
0.7426 | Intermediate Similarity | NPD5734 | Clinical (unspecified phase) |
0.7395 | Intermediate Similarity | NPD5304 | Approved |
0.7395 | Intermediate Similarity | NPD5303 | Approved |
0.7368 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7355 | Intermediate Similarity | NPD3496 | Discontinued |
0.7344 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7339 | Intermediate Similarity | NPD2797 | Approved |
0.7333 | Intermediate Similarity | NPD4235 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD5406 | Approved |
0.7328 | Intermediate Similarity | NPD5408 | Approved |
0.7328 | Intermediate Similarity | NPD5535 | Approved |
0.7328 | Intermediate Similarity | NPD5405 | Approved |
0.7328 | Intermediate Similarity | NPD5404 | Approved |
0.7321 | Intermediate Similarity | NPD9697 | Approved |
0.7297 | Intermediate Similarity | NPD9261 | Approved |
0.7273 | Intermediate Similarity | NPD3019 | Approved |
0.7273 | Intermediate Similarity | NPD3028 | Approved |
0.7273 | Intermediate Similarity | NPD4589 | Approved |
0.7273 | Intermediate Similarity | NPD2932 | Approved |
0.7265 | Intermediate Similarity | NPD2228 | Approved |
0.7265 | Intermediate Similarity | NPD2229 | Approved |
0.7265 | Intermediate Similarity | NPD2234 | Approved |
0.7252 | Intermediate Similarity | NPD2799 | Discontinued |
0.725 | Intermediate Similarity | NPD1759 | Phase 1 |
0.7238 | Intermediate Similarity | NPD9256 | Approved |
0.7238 | Intermediate Similarity | NPD9258 | Approved |
0.7232 | Intermediate Similarity | NPD9608 | Approved |
0.7232 | Intermediate Similarity | NPD9610 | Approved |
0.7227 | Intermediate Similarity | NPD9568 | Approved |
0.7222 | Intermediate Similarity | NPD5736 | Approved |
0.7213 | Intermediate Similarity | NPD3143 | Discontinued |
0.7213 | Intermediate Similarity | NPD3847 | Discontinued |
0.7203 | Intermediate Similarity | NPD5951 | Approved |
0.7203 | Intermediate Similarity | NPD9281 | Approved |
0.7182 | Intermediate Similarity | NPD2066 | Phase 3 |
0.7177 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD1758 | Phase 1 |
0.7164 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7154 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD1929 | Approved |
0.7143 | Intermediate Similarity | NPD6671 | Approved |
0.7143 | Intermediate Similarity | NPD1930 | Approved |
0.7143 | Intermediate Similarity | NPD1931 | Clinical (unspecified phase) |
0.713 | Intermediate Similarity | NPD2684 | Approved |
0.7117 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7113 | Intermediate Similarity | NPD9716 | Approved |
0.7111 | Intermediate Similarity | NPD7003 | Approved |
0.7107 | Intermediate Similarity | NPD7330 | Discontinued |
0.7107 | Intermediate Similarity | NPD3091 | Approved |
0.7105 | Intermediate Similarity | NPD1445 | Approved |
0.7105 | Intermediate Similarity | NPD1444 | Approved |
0.7097 | Intermediate Similarity | NPD9717 | Approved |
0.7097 | Intermediate Similarity | NPD3070 | Discontinued |
0.7091 | Intermediate Similarity | NPD9273 | Approved |
0.7083 | Intermediate Similarity | NPD7325 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD2688 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD3971 | Phase 1 |
0.7054 | Intermediate Similarity | NPD3268 | Approved |
0.7054 | Intermediate Similarity | NPD3764 | Approved |
0.7054 | Intermediate Similarity | NPD2313 | Discontinued |
0.7037 | Intermediate Similarity | NPD5122 | Clinical (unspecified phase) |
0.7034 | Intermediate Similarity | NPD1138 | Approved |
0.7016 | Intermediate Similarity | NPD1201 | Approved |
0.7 | Intermediate Similarity | NPD6663 | Approved |
0.7 | Intermediate Similarity | NPD4248 | Discontinued |
0.6992 | Remote Similarity | NPD4059 | Approved |
0.6991 | Remote Similarity | NPD6647 | Phase 2 |
0.6991 | Remote Similarity | NPD9500 | Approved |
0.6984 | Remote Similarity | NPD1283 | Approved |
0.6981 | Remote Similarity | NPD800 | Approved |
0.6967 | Remote Similarity | NPD1894 | Discontinued |
0.6949 | Remote Similarity | NPD228 | Approved |
0.6949 | Remote Similarity | NPD1137 | Approved |
0.6949 | Remote Similarity | NPD1139 | Approved |
0.6942 | Remote Similarity | NPD7636 | Approved |
0.6937 | Remote Similarity | NPD9495 | Approved |
0.693 | Remote Similarity | NPD5909 | Discontinued |
0.6929 | Remote Similarity | NPD1135 | Approved |
0.6929 | Remote Similarity | NPD1203 | Approved |
0.6929 | Remote Similarity | NPD1134 | Approved |
0.6929 | Remote Similarity | NPD1470 | Approved |
0.6929 | Remote Similarity | NPD1133 | Approved |
0.6929 | Remote Similarity | NPD1129 | Approved |
0.6929 | Remote Similarity | NPD1131 | Approved |
0.6923 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6798 | Discontinued |
0.6923 | Remote Similarity | NPD1792 | Phase 2 |
0.6916 | Remote Similarity | NPD1086 | Approved |
0.6916 | Remote Similarity | NPD1089 | Approved |
0.6916 | Remote Similarity | NPD1090 | Approved |
0.6911 | Remote Similarity | NPD4093 | Discontinued |
0.6905 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6893 | Remote Similarity | NPD9491 | Approved |
0.6891 | Remote Similarity | NPD7843 | Approved |
0.688 | Remote Similarity | NPD3092 | Approved |
0.688 | Remote Similarity | NPD1535 | Discovery |
0.6875 | Remote Similarity | NPD257 | Approved |
0.6875 | Remote Similarity | NPD2798 | Approved |
0.6875 | Remote Similarity | NPD258 | Approved |
0.6861 | Remote Similarity | NPD8166 | Discontinued |
0.686 | Remote Similarity | NPD6387 | Discontinued |
0.6857 | Remote Similarity | NPD9257 | Approved |
0.6857 | Remote Similarity | NPD9259 | Approved |
0.6855 | Remote Similarity | NPD2286 | Discontinued |
0.6855 | Remote Similarity | NPD5238 | Clinical (unspecified phase) |
0.6855 | Remote Similarity | NPD1778 | Approved |
0.6855 | Remote Similarity | NPD7163 | Clinical (unspecified phase) |
0.685 | Remote Similarity | NPD3225 | Approved |
0.6846 | Remote Similarity | NPD3136 | Phase 2 |
0.6837 | Remote Similarity | NPD9087 | Approved |
0.6833 | Remote Similarity | NPD1241 | Discontinued |
0.6825 | Remote Similarity | NPD1481 | Phase 2 |
0.6822 | Remote Similarity | NPD5347 | Phase 2 |
0.6822 | Remote Similarity | NPD5346 | Phase 2 |
0.6818 | Remote Similarity | NPD1693 | Approved |
0.6818 | Remote Similarity | NPD6048 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD2203 | Discontinued |
0.6818 | Remote Similarity | NPD1240 | Approved |
0.6818 | Remote Similarity | NPD6049 | Phase 2 |
0.6815 | Remote Similarity | NPD4477 | Approved |
0.6815 | Remote Similarity | NPD4476 | Approved |
0.68 | Remote Similarity | NPD9294 | Approved |
0.6794 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6794 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD4793 | Discontinued |
0.6789 | Remote Similarity | NPD1088 | Approved |
0.6783 | Remote Similarity | NPD1237 | Approved |
0.678 | Remote Similarity | NPD5451 | Approved |
0.6777 | Remote Similarity | NPD2629 | Approved |
0.6777 | Remote Similarity | NPD1476 | Clinical (unspecified phase) |
0.6777 | Remote Similarity | NPD690 | Clinical (unspecified phase) |
0.6767 | Remote Similarity | NPD6355 | Discontinued |
0.6765 | Remote Similarity | NPD2343 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD7266 | Discontinued |
0.6765 | Remote Similarity | NPD2346 | Discontinued |
0.6752 | Remote Similarity | NPD290 | Approved |
0.675 | Remote Similarity | NPD9379 | Approved |
0.675 | Remote Similarity | NPD821 | Approved |
0.675 | Remote Similarity | NPD5277 | Phase 2 |
0.675 | Remote Similarity | NPD9377 | Approved |
0.6748 | Remote Similarity | NPD16 | Approved |
0.6748 | Remote Similarity | NPD856 | Approved |
0.6746 | Remote Similarity | NPD1281 | Approved |
0.6746 | Remote Similarity | NPD1611 | Approved |
0.6744 | Remote Similarity | NPD3691 | Phase 2 |
0.6744 | Remote Similarity | NPD3690 | Phase 2 |
0.6742 | Remote Similarity | NPD5729 | Clinical (unspecified phase) |
0.6741 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6741 | Remote Similarity | NPD4308 | Phase 3 |
0.6739 | Remote Similarity | NPD3400 | Discontinued |
0.6739 | Remote Similarity | NPD3750 | Approved |
0.6739 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6738 | Remote Similarity | NPD5049 | Phase 3 |
0.6733 | Remote Similarity | NPD9088 | Approved |
0.6727 | Remote Similarity | NPD1202 | Approved |
0.6723 | Remote Similarity | NPD2181 | Clinical (unspecified phase) |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.